Oryn Therapeutics, Inc.

Overview

Oryn Therapeutics is a clinical-stage biotech developing a novel macrocyclic peptide modality—Orynotides™—to restore innate-immune homeostasis in autoimmune and chronic inflammatory diseases.

Classification

This U.S. industry comprises establishments primarily engaged in manufacturing in-vivo diagnostic substances and pharmaceutical preparations (except biological) intended for internal and external consumption in dose forms, such as ampoules, tablets, capsules, vials, ointments, powders, solutions, and suspensions.

1. Manufacturing32
2. Chemical Manufacturing325
3. Pharmaceutical and Medicine Manufacturing32541
4. Pharmaceutical Preparation Manufacturing325412

Capabilities